TP53-Agnostic Lethality through Combined Pan-HDAC and CDK Inhibition in Acute Myeloid Leukemia. Pottier A, Park S, Lee Y, Liccardo F, et al. Cancer Lett 2025 Sep 1:218011. doi: 10.1016/j.canlet.2025.218011.

Read + Share

Amedeo Smart

Independent Medical Education

Pottier A, Park S, Lee Y, Liccardo F, et al. TP53-Agnostic Lethality through Combined Pan-HDAC and CDK Inhibition in Acute Myeloid Leukemia. Cancer Lett 2025 Sep 1:218011. doi: 10.1016/j.canlet.2025.218011.
PMID: 40902843